Industry

IRVINE, Calif.–(BUSINESS WIRE)–Today Viseon Inc. announced that it recently achieved over 1,000 U.S. Minimally Invasive Spine Surgery cases utilizing the Viseon MaxView Imaging Platform. MaxView is a state-of-the-art intraoperative imaging technology that enables a highly magnified unobstructed view of the surgical corridor and critical anatomy projected in real time onto operating room flat panel displays … [Read more…]

New funding will support ongoing clinical development of lead candidate, SBT101 for adrenomyeloneuropathy (AMN) Phase 1/2 study initiation of SBT101 expected in the second half of 2022 Pipeline development to continue, focused on spinal cord-related disorders PHILADELPHIA–(BUSINESS WIRE)–SwanBio Therapeutics, a gene therapy company advancing adeno-associated virus (AAV)-based therapies for the treatment of devastating, inherited neurological … [Read more…]

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 2022 UBS Global Healthcare Conference. Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, May 25, 2022, at 9:15 am ET. … [Read more…]

Nine Seasoned Banking Professionals Comprise New Private Client Banking Team to Serve Healthcare Industry NEW YORK–(BUSINESS WIRE)–Signature Bank (Nasdaq: SBNY), a New York-based, full-service commercial bank, announced today the launch of a new business line with the appointment of a nine-person Healthcare Banking and Finance (HBF) team. The new private client banking team will provide … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others), By Application, By Distribution Channel, By Region, Competition Forecast and Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering. The global senolytic drugs market is expected to grow at a significant rate during … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cell Based Assay & High Content Screening Markets 2022 to 2026: Forecasts by User and Product. With Executive and Consultant Guides. including Customized Forecasting and Analysis. “ report has been added to ResearchAndMarkets.com’s offering. Cell Based Assays are a mainstay of drug development and scientific research, and now, post pandemic, research activity is … [Read more…]

Medidata experts to be joined by thought leaders from Moderna, Roche, Bayer, Lundbeck, Parexel, Datavant and UK’s National Institute for Health and Care Research (NIHR) LONDON–(BUSINESS WIRE)–Medidata, a Dassault Systèmes company, will gather industry experts across drug development, clinical research and operations, data management and digital health to address the industry’s most pressing challenges at … [Read more…]

First-class integrated health and wellness services that capture the growing demand in Hong Kong and other cities in the Greater Bay Area HONG KONG–(BUSINESS WIRE)–Humansa, a healthcare organization under the New World Group, today announced its new strategic focus as a premium and comprehensive provider of preventative healthcare and wellness services to capture emerging market … [Read more…]

Generation’s fourth and largest Growth Equity fund invests in teams delivering responsible innovation at scale and accelerating sustainable industry transitions LONDON & SAN FRANCISCO–(BUSINESS WIRE)–Generation Investment Management, a pure-play sustainable investment manager with over $36 billion of assets under management, today announced the launch of its $1.7 billion Sustainable Solutions Fund IV. The new fund … [Read more…]

TOKYO–(BUSINESS WIRE)–LUCA Science Inc. (LUCA Science, Tokyo, Japan) and Kyowa Kirin Co., Ltd. (Kyowa Kirin, Tokyo, Japan, TSE:4151) are pleased to announce they have entered into a research collaboration agreement on the treatment of mitochondrial diseases using platform of an innovative mitochondrial modality. Through this research collaboration, Kyowa Kirin, a leading specialty pharmaceutical company with … [Read more…]